Cite
HARVARD Citation
Pertejo-Fernandez, A. et al. (2020). Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection. Lung cancer. pp. 181-185. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pertejo-Fernandez, A. et al. (2020). Safety and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer and hepatitis B or hepatitis C infection. Lung cancer. pp. 181-185. [Online].